Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic Fibrosis

Linezolid is a treatment option for methicillin-resistant Staphylococcus aureus (MRSA) infections in cystic fibrosis (CF) patients. Little is known, however, about its pharmacokinetics in this population. Eight adults with CF were randomized to receive intravenous (i.v.) and oral linezolid at 600 mg...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Keel, Rebecca A., Schaeftlein, Andre, Kloft, Charlotte, Pope, J. Samuel, Knauft, R. Frederic, Muhlebach, Marianne, Nicolau, David P., Kuti, Joseph L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2011
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122391/
https://ncbi.nlm.nih.gov/pubmed/21518837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01797-10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires